|
IMPACTT Newsletter | November 2021
|
|
|
|
|
Welcome to our November 2021 newsletter. Check out our updates from IMPACTT, recent publications, and upcoming events you won't want to miss out on!
|
|
|
|
|
IMPACTT TEAM & NETWORK NEWS
|
|
|
|
|
|
PEOPLE ARE TALKING ABOUT
|
|
|
|
Dr. John Conly was interviewed by CTV News Calgary and the Calgary Harold about Firstline, a new veterinary app developed at the University of Calgary that aims optimize the use of antibiotics in animals to help reduce antimicrobial resistance.
|
|
|
NEW PUBLICATIONS
|
|
|
New Publications in the Microbiome World
|
Lam et al. Cell Reports. 2 November 2021
|
Highlights: In this study, researchers used CRISPR-Cas9 to manipulate the genomes of E. coli bacteria living within mouse gastrointestinal (GI) tracts via engineered bacteriophage. The researchers hope this proof-of-concept study will lead to targeted therapeutic approaches that are species- or even strain-specific in the future.
|
|
Yap et al. Cell. 11 November 2021
|
Highlights: This new study challenges the popular hypothesis that the gut microbiome causally contributes to autism spectrum disorder (ASD). In this study, researchers performed a stool metagenomics study on 247 samples from the Australian Autism Biobank and the Queensland Twin Adolescent Brain project, and found "negligible direct associations between ASD diagnosis and the gut microbiome." Instead, the researchers suggest that restricted diet preferences associated with ASD may lead to lower microbial diversity.
|
|
Weinstein et al. PNAS. 23 November 2021
|
Highlights: In this study, researchers characterized the diets and microbiomes of wild woodrats belonging to 7 species of the genus Neotoma located across the southwestern United States. They then brought some of these wild animals into captivity to determine how captivity altered their microbiomes. They found that in nature, geography, diet, and species explained approximately 50% of the observed microbiome variation among the population. In captivity, microbiome composition changed, but this change was species-specific, highlighting the importance of genetics in determining microbiome composition.
|
New Publications from our IMPACTT Team
|
Dr. Paul Kubes (Platform 1 Co-Lead)
|
Babes, Shim, & Kubes. Cancer Immunology Research. 16 Nov 2021.
|
Neupane & Kubes. Immunological Reviews. 23 Nov 2021.
|
|
Dr. Fiona Brinkman (Platform 5 Co-Lead)
|
Brinkman et al. Advances in Microbial Physiology. 16 Nov 2021.
|
|
Dr. Braedon McDonald (Education & Mentorship Co-Lead)
|
Kim et al. Frontiers in Immunology. 11 Nov 2021.
|
Sinha et al. Nature Medicine. 15 Nov 2021.
|
|
Dr. Jayne Danska (Sex & Gender Lead)
|
|
Rajakumar & Danska. Molecular & Cellular Oncology. 6 Nov 2021.
|
|
|
UPCOMING EVENTS AND REMINDERS
|
|
|
Click here to see a list of upcoming events in the microbiome world.
|
|
|
The IMPACTT Mentorship Program is now accepting applications for our 2022-2023 cohort. Click here to learn more about our program and apply today!
|
Application Deadline: 31 January, 2022
|
|
|
|
|
|
|
CALL FOR PAPERS
|
|
|
Microbial Pathogenesis has a call for papers in collaboration with Current Research in Microbial Sciences and Current Research in Immunology for a special collection called Advances in Microbial Pathogenesis and Host Immunity. Deadline: 31 Dec, 2021.
|
|
|
Be a contributor to our microbiome community!
|
|
|
|
|
|
|
|
|
|
|
|
